Firm argues breast biopsy case with FDA

Article

U.S. Surgical of Norwalk, CT, is in discussions with the Foodand Drug Administration regarding what the agency claims is inappropriateadvertising of the firm's Advanced Breast Biopsy Instrumentation(ABBI) system (SCAN 5/22/96). The skirmish may say more

U.S. Surgical of Norwalk, CT, is in discussions with the Foodand Drug Administration regarding what the agency claims is inappropriateadvertising of the firm's Advanced Breast Biopsy Instrumentation(ABBI) system (SCAN 5/22/96). The skirmish may say more aboutthe FDA's slow-changing internal organization than any marketingmalfeasance.

According to the FDA's June 3 warning letter to U.S. Surgical,ABBI, originally called the Auto Suture Biopsy Device, was given510(k) clearance as a gastroenterology-urology biopsy instrument.The problem is that the company is promoting the system for breastbiopsy applications, said Marcia Meyer, FDA public affairs specialist.

That is not the case, countered Steve Rose, director of mediarelations for U.S. Surgical. The company submitted an applicationfor a biopsy device, which was then routed to the GI and urinarydivision because that is the only FDA group that handles biopsyequipment marketing applications.

The company's 510(k) clearance document makes several referencesto mammography and breasts, he said. It also mentions the Loradtable used with ABBI, which is designed for breast applications.Finally, the predicate core-needle biopsy system mentioned inthe 510(k) process was used in breast applications.

"We went to the FDA with a biopsy device and they said`You need to submit this to our GI and urinary division.' Thereis no division that evaluates breast biopsy (devices)."

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.